CEL SCI CORP
CEL SCI CORP (CVM): 3 pipeline candidates · ~2 mo cash runway. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
1.6 months
D/E 1.58 · 0% dilution
Lead: Phase 3
3 candidates
N/A
3 buys · 0 sells (180d)
A transparent, data-derived signal for CEL SCI CORPacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$14.6M
Cash
$1.9M
Quarterly Burn
$4.0M
Runway
1.6 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
| Drug | Phase |
|---|---|
| L.E.A.P.S. | Preclinical |
| L.E.A.P.S. (Ligand Epitope Antigen Presentation System) | Preclinical |
| Multikine | Phase 3 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
36
Total value held
$2.8M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 487,290 | $1.6M |
| geode capital management, llc | 85,311 | $274K |
| vanguard fiduciary trust co | 49,036 | $157K |
| blackrock, inc. | 43,261 | $139K |
| bank of america corp /de/ | 40,997 | $132K |
| renaissance technologies llc | 35,890 | $115K |
| state street corp | 27,270 | $88K |
| xtx topco ltd | 22,556 | $72K |
| northern trust corp | 18,934 | $61K |
| commonwealth equity services, llc | 17,622 | $57K |
Showing top 10 of 36 institutional holders of CEL SCI CORP. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in CEL SCI CORP's pipeline?
CEL SCI CORP (CVM) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is CEL SCI CORP's lead drug candidate?
CEL SCI CORP's most advanced tracked candidate is L.E.A.P.S. (Preclinical) for Rheumatoid arthritis.
What is CEL SCI CORP's cash runway?
Based on its most recent reported cash balance and quarterly burn rate, CEL SCI CORP has approximately 1.6 months of cash runway.
What is CEL SCI CORP's market capitalization?
CEL SCI CORP's market capitalization is approximately $14.6M.
Who is the CEO of CEL SCI CORP?
Mr. Geert R. Kersten Esq. is the chief executive officer of CEL SCI CORP (CVM).
Get the full picture on CEL SCI CORP
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.